Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)
|
Spiroperidol chemical structure | |
| 8-[4-(4-fluorophenyl)-4-oxo-butyl]-1-phenyl- 1,3,8-triazaspiro[4.5]decan-4-one IUPAC name | |
| CAS number 749-02-0 |
ATC code [[ATC_code_|]][1] |
| PubChem 5265 |
DrugBank [2] |
| Chemical formula | {{{chemical_formula}}} |
| Molecular weight | 395.47 g/mol |
| Bioavailability | |
| Metabolism | Hepatic |
| Elimination half-life | |
| Excretion | Renal |
| Pregnancy category | {{{pregnancy_category}}} |
| Legal status | |
| Routes of administration | Oral |
Spiroperidol (also known as Spiperone, Spiropitan) is a drug which is a butyrophenone derivative. It acts on subsets of both 5-HT receptors and dopamine receptors, and is used to treat schizophrenia.
Template:Dopamine antagonists
| This page uses Creative Commons Licensed content from Wikipedia (view authors). |